Micellar nanoparticle formation via electrostatic interactions for delivering multinuclear platinum(ii) drugs

The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy

(2012) Haihua Xiao et al.   BIOMATERIALS

Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance and show enhanced efficacy in vivo

(2012) T Kiziltepe et al.   Blood Cancer Journal

Biodegradable polymer − cisplatin(IV) conjugate as a pro-drug of cisplatin(II)

(2011) Haihua Xiao et al.   BIOMATERIALS

Shape-specific polymeric nanomedicine: emerging opportunities and challenges

(2011) Li Tao et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy

(2010) Abhimanyu S. Paraskar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Peptide-Targeted Polyglutamic Acid Doxorubicin Conjugates for the Treatment of αvβ6-Positive Cancers

(2008) Huili Guan et al.   BIOCONJUGATE CHEMISTRY

Nanoparticle therapeutics: an emerging treatment modality for cancer

(2008) Mark E. Davis et al.   NATURE REVIEWS DRUG DISCOVERY